- Profile
- Personal Information
- Publications
Experts in Clinical Research
Anna Akinshina Elizabeth R. Dumont Alexander R. Gerson Dr. Sateesh B Arja Anita Airee Peter J. Embi N. Elagovan Shaun Grannis Dr. Patricia Rhynders Beulah Shekha Johanne Eliacin Bert van der Zwaan Frank Caligiuri Renae Chesnut Cheryl Clarke Andrew Miesner Dr. David Amor Thomas Felzmann Avihu Boneh John Carlin View MoreCaley Castelein, M.D.
Founder and Managing Member of Kearny Venture Part
Founder and Managing Member of Kearny Venture Partners and K
NewBridge Pharmaceuticals FZ LLC
United Arab Emirates
Caley is a founder and managing member of Kearny Venture Partners and KVP Capital. Caley is a current board member of Alivecor, Boreal, Newbridge Pharmaceuticals, ViewRay, WellPartner, and Waterstone Pharmaceuticals. At Kearny, his previous investments include Aspreva (acquired by Gelenica), CoTherix (acquaired by Actelion), Kai (acquired by Amgen), Roxro (acquired by a unit of Daiichi Sankyo), and QuatRx (partnered with Shionogi). Caley received his M.D. from the University of California, San Francisco, with honors. During medical school, he ran a research program investigating the genetic causes of deafness and the application of gene therapy to treatment of hearing loss. The findings were published in leading journals including Nature Genetics. After medical school, Caley completed a general surgery internship at the University of California, San Francisco. He received an A.B. magna cum laude from Harvard College.
Nature Genetics